Beta-glucan is a sugar chain from yeast, oats or mushrooms that holds water and sits on skin as a soft film. Its strongest human evidence comes from chronic ulcers and burns, not intact faces, and at roughly 400–1,600 kDa it is far too large to cross a healthy stratum corneum. On your face, the film is most of the story.
At the studio in Hongdae, beta-glucan essences turn up in a lot of visitors' bags, usually bought on the first afternoon somewhere near the station. The people who like them most are the ones who arrived already stinging: wind-chapped, over-exfoliated, two days into a routine packed for a different climate. That pattern is worth taking seriously. It is also not the same thing as the ingredient doing what the label implies.
What is beta-glucan, and where does yours come from?
Beta-glucan is a polysaccharide — a long chain of glucose units — that makes up part of the cell wall of yeast, mushrooms and cereal grains, and in skincare it is used as a water-binding, film-forming soothing agent rather than as something that rebuilds skin. The source changes the molecule far more than most labels admit. A structural review published in Fibers in 2020 reports oat beta-glucan at around 1,100–1,600 kDa, soluble mushroom beta-glucans from maitake and shiitake at about 400 kDa, and carboxymethylated derivatives — the modified, cold-water-soluble form common in cosmetics — much lower, around 63 kDa for one Ganoderma preparation.
Those are not small differences. A carboxymethyl glucan and a native oat beta-glucan share a name on an ingredient list and differ by more than an order of magnitude in size, which changes how they dissolve, how viscous they are, and what they can plausibly do once they are on skin.
How much was in the research, and how much is in your essence?
The human studies I could read in full used 2%. In a randomised, double-blind, placebo-controlled phase II trial (NCT00288392), 60 outpatients with diabetic foot or lower-leg ulcers received either a 2% aqueous soluble yeast beta-1,3/1,6-glucan or 2% methylcellulose, applied three times weekly for up to 12 weeks. That is the concentration the evidence is about.
Your essence almost certainly does not tell you its own percentage. Korean ingredient lists are ordered by concentration only down to 1%, so if beta-glucan sits below the preservatives you are looking at a fraction of a percent — and nothing obliges anyone to say which fraction. In Seoul you will meet it in three broad formats: thin watery essences where it is one humectant among several; thicker single-ingredient ampoules sold as barrier products; and sheet-mask serums, where a good part of its job is giving the essence slip and cling. Pharmacies here stock very little of it in isolation. In Korea it is a cosmetic ingredient, not a pharmacy item, which is itself informative.
Can a molecule this large get through intact skin?
Almost certainly not in one piece. The standard reference point is Bos and Meinardi's 2000 paper in Experimental Dermatology, which argued from three independent lines of evidence — the molecular weights of common contact allergens, of topical dermatological drugs, and of every drug then used in transdermal patches — that a compound generally needs a molecular weight under 500 Dalton to be absorbed through intact skin, and that larger molecules cannot pass the corneal layer. Every transdermal drug they surveyed came in under 350 Dalton.
Beta-glucan at 400,000 to 1,600,000 Dalton is not near that threshold. It is three orders of magnitude past it. What we do know is that it binds water well and forms a cohesive film that reduces how fast water leaves the surface. What we do not know, honestly, is how much of the receptor-level activity shown in laboratory work translates to a molecule sitting on top of an intact stratum corneum rather than in contact with living tissue. That distinction is the entire question, and it is the one usually skipped.
Why do eyes, neck and the corners of the mouth behave differently?
Because the barrier there is thinner and moves more, so the same product has a different job to do. Eyelid skin is the thinnest on the face; the neck has fewer oil glands than the cheek and folds constantly. A film-former that feels elegant on a cheek can feel heavy on the neck by evening, or migrate into the eye. There is a second, less comfortable implication: when the barrier is actually broken in those areas — and that is usually where it breaks first — the 500 Dalton logic weakens, because compromised skin is a different permeability situation from intact skin. That is a reason to be gentler there. It is not a reason to expect more.
Know your own skin before you buy anything
Ingredients should be introduced in steps, matched to the state your skin is in this week rather than the state you would like it to be in. The most common mistake I see is someone whose barrier is already struggling deciding that the answer is to add every well-reviewed thing at once. That is the logic of a person who is seriously ill deciding to get healthy by training harder. What the body needs at that point is rest, not more input.
When the barrier is down — stinging on application, tightness, flaking at the sides of the nose, redness that does not settle overnight — the first move is subtraction, not addition. Cut back to a gentle cleanser, one bland moisturiser and sunscreen. Hold there for a week or two. Only then add a single new thing, and give it long enough to actually tell you something. Beta-glucan is a reasonable candidate for that single thing, because its irritation risk is low. Low risk is not the same as proven benefit.
None of this replaces medical diagnosis or treatment. If something is painful, spreading, or simply not settling, that is a dermatologist's question rather than an ingredient question.
The case against some of this
Three of the claims I have just made deserve pushing on, so I went looking for the evidence against them.
- "The human evidence supports beta-glucan." It is thinner than I implied. A systematic review and meta-analysis in Wound Practice and Research pooled only four human studies — two randomised controlled trials and two retrospective cohorts, roughly 644 participants in total. Chronic wounds did favour beta-glucan (odds ratio 2.14, 95% CI 1.31–3.47), but both RCTs were rated high risk of bias on RoB 2, acute wounds showed no significant benefit (mean difference −1.70 days, 95% CI −4.58 to 1.18), and the authors state plainly that the evidence supporting clinical use remains inconclusive.
- "The trial data show it works." The phase II ulcer trial I cited above did not meet its primary endpoint. Median time to healing was 36 days with beta-glucan versus 63 with placebo, which sounds decisive until you reach the p-value: 0.1298. The significant findings were secondary and exploratory, unadjusted for multiple testing, and the two study centres produced results that differed in ways the authors could not explain.
- "It is a serious Korean skincare active." Not in regulatory terms. Korea's Cosmetics Act recognises a closed set of functional categories — whitening, wrinkle improvement, UV protection, hair, and barrier-related dryness and itch — and a product may only make those claims through MFDS review or a report that matches notified ingredients at notified concentrations. Beta-glucan is not on that notified list the way adenosine or niacinamide are. There is no officially agreed concentration at which it is held to do anything at all.
So let me narrow rather than withdraw: on intact but irritated skin, beta-glucan is a good humectant and film-former with a low irritation risk and a fair claim to making skin feel better quickly. That is the whole of what I will say for it.
Is beta-glucan better than hyaluronic acid?
Both are humectants, and I cannot point to a head-to-head human trial that settles it. Beta-glucan is the larger molecule and forms a more cohesive film, which some people find more comfortable on reactive skin. If you are trying to learn something about your own skin, use one of them, not both.
Can I use beta-glucan with retinol or acids?
There is no known chemical incompatibility, and a humectant layer is a common way to cushion an active. But if your skin is currently reacting to the retinol, the useful change is less retinol, not more cushion on top of it.
Is beta-glucan safe to use in pregnancy?
Topical polysaccharides are not generally flagged as a concern, but pregnancy skincare questions belong to your doctor rather than to an ingredient list. Ask them about the routine as a whole rather than about one bottle.
If you are in Seoul and your skin is in the stripped-and-stinging state this article keeps describing, one more bottle is rarely the answer — the order and the spacing usually matter more than the ingredient. Working that order out is what a 1:1 consultation at Laurel Studio in Hongdae is for: what to remove first, what to hold, and what to add only once your barrier is steady enough to tell you something useful. Bring whatever you have already bought.
Sources
- Bos JD, Meinardi MMHM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology 2000;9:165–169. PubMed record — full text read.
- Zykova SN et al. Macrophage stimulating agent soluble yeast beta-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: randomised, double-blind, placebo-controlled phase II study (NCT00288392). 60 patients. Full text (PDF) — full text read.
- Structural Features, Modification, and Functionalities of Beta-Glucan. Fibers 2020;8(1):1. Open access — full text read; source of the molecular weight figures.
Sources for "The case against some of this"
- The effect of beta-glucan on wound healing: a systematic review and meta-analysis. Wound Practice and Research, vol. 33 no. 4. 4 studies, ~644 participants, 2 RCTs at high risk of bias. Full text — full text read.
- Zykova et al. (above), limitations and primary-endpoint sections: primary endpoint not met, p = 0.1298; secondary analyses exploratory and unadjusted; unexplained between-centre differences.
- Korea Ministry of Food and Drug Safety functional cosmetics review and reporting system, under the Cosmetics Act and its Enforcement Rule. Korea Easy Law portal — full text read.
